You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A NEW METHOD FOR MONITORING SPECIFIC NEUROTRANSMITTERS
SBC: CC Technology Topic: N/ADESCRIPTION (provided by applicant): The proposed research will develop two prototype analyzers, one of which will be interfaced with a perfusion probe for neurotransmitters, and their metabolites, Surface Enhanced Raman Assay (SERA) using Surface Enhanced Resonance Raman Scattering (SERRS). The first prototype will be placed in a translational researc ...
STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
Detection of Multiple Chemical Warfare Agents
SBC: CC Technology Topic: N/ADESCRIPTION (provided by applicant): The goal of this Phase I STTR project is the development of an analytical method for the rapid detection of a variety of chemical warfare (CW) agents. A large number of methods have been used for the detection of CW agents, but they are generally not well suited for use under battlefield conditions, due to size, speed of analysis, power requirements or fragilit ...
STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Radionuclide imaging and therapy dosimetry system
SBC: Computerized Medical Systems, Inc. Topic: N/ADESCRIPTION (Provided by Applicant): The objective of this Phase I proposal is to determine the scientific, technical, and commercial merit and feasibility of an integrated commercial treatment planning and dosimetry system (RTDS) for radionuclide therapy and radionuclide imaging, especially for radioimmunotherapy (AlT). In clinical and experimental RIT, ...
STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
Intraperitoneal Nanoparticulate Paclitaxel
SBC: CRITITECH Topic: N/ADESCRIPTION (provided by applicant): Paclitaxel has shown promise in the treatment of several types of cancers, including ovarian cancer. The long-term goals of this research are to design a formulation of paclitaxel that is effective in the treatment of cancer and exhibits no formulation related toxicity. The present set of studies utilizes the techniques of precipitation with compressed antisol ...
STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: Detection Limit, Inc. Topic: N/AN/A
STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: Detection Limit, Inc. Topic: N/AN/A
STTR Phase II 2000 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: DNA POLYMERASE TECHNOLOGY, INC. Topic: N/AN/A
STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health -
Development of an Adjustable Intraocular Lens
SBC: EAGLE ADJUSTABLE LENS Topic: N/ADESCRIPTION: The goal of this Phase I STTR program will be to develop an adjustable intra-ocular lens (IOL). The concept is novel and has the potential to reduce the rehabilitation time of patients receiving an artificial IOL. The proposed technique and design, in conjunction with traditional intra- ...
STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
Development of a Mitochondrial Disease Profiling Array
SBC: GENEPROTECH,INC. Topic: N/ADESCRIPTION (provided by applicant): Mitochondrial disease caused by point mutations in mitochondrial DMA (mtDNA) can be a formidable diagnostic challenge. Because clinical presentation can be variable, multisystemic, and mimic many other neurological disorders, ruling out an mtDNA etiology is difficult in patients with suspected myopathies or encephalopathies. DMA microarrays would seem to prov ...
STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Development of High Temperature Cryopreservation Medium for Storage and Shipping
SBC: IMPACT BIOLABS, LLC Topic: N/ADESCRIPTION (provided by applicant): One of the most expensive aspects of a cryopreservation program is related to ongoing, long-term storage and shipping of samples at very low temperatures (typically between - 196oC, the temperature of liquid nitrogen (L N2), and approximately -120oC, in the high- end temperature range of LN2 vapor). Current approaches to cryopreserving most cells and tissues, i ...
STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health